Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway

Cancer Letters

Volumn 308, Issue 2, 2011, Pages 181-188

  Phillips, P A ^a,b   Sangwan, V ^a   Borja Cacho, D ^a   Dudeja, V ^a   Vickers, S M ^a   Saluja, A K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Apoptosis; Myricetin; Orthotopic model; Pancreatic cancer

Indexed keywords

CASPASE 3; CASPASE 9; HEAT SHOCK PROTEIN 70; MYRICETIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER REGRESSION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FLAVONOIDS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 79959564406     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.05.002     Document Type: Article

References (31)

1. Birt D.F., Hendrich S., Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 2001, 90:157-177.
2. Bosetti C., Spertini L., Parpinel M., Gnagnarella P., Lagiou P., Negri E., Franceschi S., Montella M., Peterson J., Dwyer J., Giacosa A., La Vecchia C. Flavonoids and breast cancer risk in Italy. Cancer Epidemiol. Biomarkers Prev. 2005, 14:805-808.
3. Theodoratou E., Kyle J., Cetnarskyj R., Farrington S.M., Tenesa A., Barnetson R., Porteous M., Dunlop M., Campbell H. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16:684-693.
4. Aghdassi A., Phillips P., Dudeja V., Dhaulakhandi D., Sharif R., Dawra R., Lerch M.M., Saluja A. Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res. 2007, 67:616-625.
5. Mouria M., Gukovskaya A.S., Jung Y., Buechler P., Hines O.J., Reber H.A., Pandol S.J. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer 2002, 98:761-769.
6. Shih Y.W., Wu P.F., Lee Y.C., Shi M.D., Chiang T.A. Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway. J. Agric. Food. Chem. 2009, 57:3490-3499.
7. Walker E.H., Pacold M.E., Perisic O., Stephens L., Hawkins P.T., Wymann M.P., Williams R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell 2000, 6:909-919.
8. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 1997, 53:1649-1657.
9. Hou D.X., Kai K., Li J.J., Lin S., Terahara N., Wakamatsu M., Fujii M., Young M.R., Colburn N. Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. Carcinogenesis 2004, 25:29-36.
10. Kandaswami C., Lee L.T., Lee P.P., Hwang J.J., Ke F.C., Huang Y.T., Lee M.T. The antitumor activities of flavonoids. In Vivo 2005, 19:895-909.
11. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 2004, 36:838-849.
12. Koren J., Jinwal U.K., Jin Y., O'Leary J., Jones J.R., Johnson A.G., Blair L.J., Abisambra J.F., Chang L., Miyata Y., Cheng A.M., Guo J., Cheng J.Q., Gestwicki J.E., Dickey C.A. Facilitating Akt clearance via manipulation of Hsp70 activity and levels. J. Biol. Chem. 2010, 285:2498-2505.
13. Schreiber F.S., Deramaudt T.B., Brunner T.B., Boretti M.I., Gooch K.J., Stoffers D.A., Bernhard E.J., Rustgi A.K. Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene. Gastroenterology 2004, 127:250-260.
14. Phillips P.A., Dudeja V., McCarroll J.A., Borja-Cacho D., Dawra R.K., Grizzle W.E., Vickers S.M., Saluja A.K. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res. 2007, 67:9407-9416.
15. Kroemer G., Levine B. Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 2008, 9:1004-1010.
16. Dudeja V., Mujumdar N., Phillips P., Chugh R., Borja-Cacho D., Dawra R.K., Vickers S.M., Saluja A.K. Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms. Gastroenterology 2009, 136:1772-1782.
17. Duthie S.J., Johnson W., Dobson V.L. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimdines) and growth in human cells. Mutat. Res. 1997, 390:141-151.
18. Kuntz S., Wenzel U., Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 1999, 38:133-142.
19. Zhang Q., Zhao X.H., Wang Z.J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol. 2008, 46:2042-2053.
20. Carli C.B., de Matos D.C., Lopes F.C., Maia D.C., Dias M.B., Sannomiya M., Rodrigues C.M., Andreo M.A., Vilegas W., Colombo L.L., Carlos I.Z. Isolated flavonoids against mammary tumour cells LM2. Z. Naturforsch. C 2009, 64:32-36.
21. Alexandrakis M., Letourneau R., Kempuraj D., Kandere-Grzybowska K., Huang M., Christodoulou S., Boucher W., Seretakis D., Theoharides T.C. Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1). Eur. J. Haematol. 2003, 71:448-454.
22. Wang I.K., Lin-Shiau S.Y., Lin J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer 1999, 35:1517-1525.
23. Yanez J., Vicente V., Alcaraz M., Castillo J., Benavente-Garcia O., Canteras M., Teruel J.A. Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr. Cancer 2004, 49:191-199.
24. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 2000, 6:513-519.
25. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
26. Ko C.H., Shen S.C., Lee T.J., Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol. Cancer Ther. 2005, 4:281-290.
27. Jinwal U.K., Miyata Y., Koren J., Jones J.R., Trotter J.H., Chang L., O'Leary J., Morgan D., Lee D.C., Shults C.L., Rousaki A., Weeber E.J., Zuiderweg E.R., Gestwicki J.E., Dickey C.A. Chemical manipulation of hsp70 ATPase activity regulates tau stability. J. Neurosci. 2009, 29:12079-12088.
28. Zhang Y.S., Zhang Q.Y., Li L.Y., Wang B., Zhao Y.Y., Guo D.A. Simultaneous determination and pharmacokinetic studies of dihydromyricetin and myricetin in rat plasma by HPLC-DAD after oral administration of Ampelopsis grossedentata decoction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 860:4-9.
29. Bondar V.M., Sweeney-Gotsch B., Andreeff M., Mills G.B., McConkey D.J. Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol. Cancer Ther. 2002, 1:989-997.
30. Teranishi F., Takahashi N., Gao N., Akamo Y., Takeyama H., Manabe T., Okamoto T. Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo. Cancer Sci. 2009, 100:770-777.
31. Fujiwara M., Izuishi K., Sano T., Hossain M.A., Kimura S., Masaki T., Suzuki Y. Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells. J. Exp. Clin. Cancer Res. 2008, 27:76.